Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars

The Lilly Biotechnology Center in San Diego, California, on March 1, 2023.

Mike Blake | Reuters

Eli Lilly on Thursday reported mixed results for the fourth quarter as sales of its blockbuster weight loss and diabetes drugs soared but it saw lower realized prices.

The figures were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors. Eli Lilly had slashed its 2024 revenue guidance, as it said demand for its weight loss and diabetes drugs would not meet its lofty expectations.

The company’s earnings topped Wall Street estimates, but sales fell just short.

Here’s what Eli Lilly reported for the period compared with what Wall Street was expecting, based on a survey of analysts by LSEG:

Earnings per share: $5.32 adjusted vs. $4.95 expected
Revenue: $13.53 billion vs. $13.57 billion expected

This story is developing. Please check back for updates.

Source

Health

Trump’s pharmaceutical tariffs could affect some drugmakers more than others

July 29, 2025

Medications are stored on shelves at a pharmacy on May 12, 2025 in Los Angeles, California. Eric Thayer | Getty Images President Donald Trump is slated to impose tariffs on pharmaceuticals imported into the U.S. any day now – and the duties may have a bigger impact on some drugmakers than others, according to some […]

Merck plans billion cost cuts by end of 2027, narrows full-year outlook

Health

Merck plans $3 billion cost cuts by end of 2027, narrows full-year outlook

July 29, 2025

Merck & Co. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Tuesday, April 8, 2025. Michael Nagle | Bloomberg | Getty Images Merck on Tuesday said it will slash $3 billion in costs by the end of 2027 to be fully reinvested to support new product launches […]

Health

UnitedHealth says 2025 earnings will be worse than expected as high medical costs dog insurers

July 29, 2025

UnitedHealthcare signage is displayed on an office building in Phoenix, Arizona, on July 19, 2023. Patrick T. Fallon | Afp | Getty Images UnitedHealth Group on Tuesday issued a 2025 outlook that fell short of Wall Street’s expectations, as the company’s insurance unit continues to grapple with higher medical costs. The company anticipates it will […]